Terms: = Head and neck cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
432 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral cancer Cells.
Yadav AK; Wang S; Shin YM; Jang BC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
[TBL] [Abstract] [Full Text] [Related]
3. Potential targets of diosgenin for the treatment of oral squamous cell carcinoma and their bioinformatics and transcriptional profiling analyses.
Xiao Y; Xu B; Li X; Ding T; Zhao W; Nie X; Mu J; Xiao Z; Wang Q; Ren Q; Zhang E
Steroids; 2024 May; 205():109393. PubMed ID: 38458369
[TBL] [Abstract] [Full Text] [Related]
4. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
[TBL] [Abstract] [Full Text] [Related]
5. IGF2BP2 promotes cell invasion and epithelial-mesenchymal transition through src-mediated upregulation of EREG in oral cancer.
Lin CW; Yang WE; Su CW; Lu HJ; Su SC; Yang SF
Int J Biol Sci; 2024; 20(3):818-830. PubMed ID: 38250159
[TBL] [Abstract] [Full Text] [Related]
6. Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression.
Chen L; Zhu S; Liu T; Zhao X; Xiang T; Hu X; Wu C; Lin D
Signal Transduct Target Ther; 2023 Dec; 8(1):453. PubMed ID: 38097539
[TBL] [Abstract] [Full Text] [Related]
7. Exploring the pharmacological mechanisms of Biyan Qingdu Granula in the treatment after nasopharyngeal carcinoma radiotherapy based on UPLC/Q-TOF MS, network pharmacology and molecular docking.
Yi B; Lv F; Zhang N; Lin J; Xu K; Li C; Li P; Zhao M
J Pharm Biomed Anal; 2024 Feb; 239():115830. PubMed ID: 38096633
[TBL] [Abstract] [Full Text] [Related]
8. AKT-independent signaling in PIK3CA-mutant thyroid cancer mediates resistance to dual src and MEK1/2 inhibition.
Rose MM; Nassar KW; Sharma V; Schweppe RE
Med Oncol; 2023 Sep; 40(10):299. PubMed ID: 37713162
[TBL] [Abstract] [Full Text] [Related]
9. SLA2 is a prognostic marker in HNSCC and correlates with immune cell infiltration in the tumor microenvironment.
Wu Z; You C; Zhu Z; Wu W; Cao J; Xie Q; Deng C; Huang X; Hu S
Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):427-440. PubMed ID: 37688682
[TBL] [Abstract] [Full Text] [Related]
10. Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancer.
Dong H; Li M; Chen H; Tian L; Wei W; Wang S; Cheng G; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15055-15067. PubMed ID: 37610675
[TBL] [Abstract] [Full Text] [Related]
11. Nonfunctional TGF-β/ALK1/ENG signaling pathway supports neutrophil proangiogenic activity in hereditary hemorrhagic telangiectasia.
Duerig I; Pylaeva E; Ozel I; Wainwright S; Thiel I; Bordbari S; Domnich M; Siakaeva E; Lakomek A; Toppe F; Schleupner C; Geisthoff U; Lang S; Droege F; Jablonska J
J Leukoc Biol; 2023 Nov; 114(6):639-650. PubMed ID: 37555392
[TBL] [Abstract] [Full Text] [Related]
12. Intensified Adjuvant Treatment for High-Risk Resected Cutaneous Angiosarcoma of the head and neck.
El Shatanofy M; Thakkar P; Patel V; Joshi A; Goodman J; Siegel R; Haroun F; Ojong-Ntui M; Goyal S; Bauman J; Rao YJ
Otolaryngol Head Neck Surg; 2023 Nov; 169(5):1225-1233. PubMed ID: 37464928
[TBL] [Abstract] [Full Text] [Related]
13. Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity.
Bolf EL; Beadnell TC; Rose MM; D'Alessandro A; Nemkov T; Hansen KC; Schweppe RE
Cells; 2023 May; 12(10):. PubMed ID: 37408209
[TBL] [Abstract] [Full Text] [Related]
14. Network Toxicology Prediction and Molecular Docking-based Strategy to Explore the Potential Toxicity Mechanism of Metformin Chlorination Byproducts in Drinking Water.
Zhang GH; Liu H; Liu MH; Liu YC; Wang JQ; Wang Y; Wang X; Xiang Z; Liu W
Comb Chem High Throughput Screen; 2024; 27(1):101-117. PubMed ID: 37170985
[TBL] [Abstract] [Full Text] [Related]
15. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
Singh DR; Nelson SE; Pawelski AS; Kansra AS; Fogarty SA; Bristol JA; Ohashi M; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2219755120. PubMed ID: 37155846
[TBL] [Abstract] [Full Text] [Related]
16. CX3CL1 induces cell migration and invasion through ICAM-1 expression in oral squamous cell carcinoma cells.
Wu CY; Peng PW; Renn TY; Lee CJ; Chang TM; Wei AI; Liu JF
J Cell Mol Med; 2023 Jun; 27(11):1509-1522. PubMed ID: 37082943
[TBL] [Abstract] [Full Text] [Related]
17. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
18. src inhibition induces mitotic arrest associated with chromosomal passenger complex.
Yang S; Luo Y; Yang M; Ni H; Yin H; Hu M; Liu M; Zhou J; Yang Y; Li D
Cell Tissue Res; 2023 Jun; 392(3):733-743. PubMed ID: 36988705
[TBL] [Abstract] [Full Text] [Related]
19. Machilin D Promotes Apoptosis and Autophagy, and Inhibits Necroptosis in Human Oral Squamous Cell Carcinoma Cells.
Yun HM; Kwon YJ; Kim E; Chung HJ; Park KR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902006
[TBL] [Abstract] [Full Text] [Related]
20. Improving Hands-Free Speech Rehabilitation in Laryngectomized Patients with a Moldable Adhesive.
Leemans M; Longobardi Y; Dirven R; Honings J; D'Alatri L; Galli J; van den Brekel M; Parrilla C; van Sluis KE
Laryngoscope; 2023 Nov; 133(11):2965-2970. PubMed ID: 36883657
[TBL] [Abstract] [Full Text] [Related]
[Next]
